Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
60 Degrees Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SXTP
Nasdaq
2834
www.60degreespharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
- May 26th, 2026 6:02 am
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
- May 15th, 2026 6:42 am
Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates
- May 13th, 2026 3:15 pm
Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates
- May 11th, 2026 7:10 am
RedChip's Biotech Investor Conference Replays Now Available
- Apr 20th, 2026 6:00 am
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
- Apr 15th, 2026 6:02 am
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know
- Apr 3rd, 2026 10:00 am
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Apr 2nd, 2026 7:00 am
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
- Apr 2nd, 2026 6:45 am
60 Degrees Pharmaceuticals Announces 2025 Annual Results
- Mar 31st, 2026 5:01 am
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
- Mar 18th, 2026 6:01 am
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
- Mar 11th, 2026 5:24 am
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Feb 27th, 2026 7:00 am
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA
- Feb 24th, 2026 11:10 am
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy?
- Feb 7th, 2026 7:05 pm
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
- Feb 2nd, 2026 6:01 am
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
- Jan 28th, 2026 6:01 am
Sector Update: Health Care Stocks Mixed Late Afternoon
- Jan 22nd, 2026 1:54 pm
Top Midday Gainers
- Jan 22nd, 2026 11:58 am
Sector Update: Health Care Stocks Rise in Afternoon Trading
- Jan 22nd, 2026 11:51 am
Scroll